chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt states that around 9 PM that night after getting vaccines she stated shaking violently.  She was shivering, freezing, had 101.9 fever, headache, along with body aches.  After a few hours her left arm became extremely itchy.  She had 3 chicken pox bumps.  Next day she forced herself to eat toast and have tea so she could take an ibuprofen.  She was able to drink some water.   She was in bed for a day and half with flu like symptoms and was some better after about 3 days.  Then her joints became achy and started hurting.  She states her rheumatoid arthritis became inflamed with the worst pain she has ever had.  She developed nodules on her finger and toe.  Her pain was out of control.  She saw her doctor on June 13th and was confirmed with chicken pox and was put on steroids for three days to help with joint pain.  She was taken off steroids so she could take her allergy shots but 2 days after coming off of them she had to go back on the steroids to help with the pain.  She is still on the tapered steroids but is about to be finished with them.  She is feeling some better but is concerned the pain with return upon completion.   She received 1st dose of the Shringrix vaccine on 3/21/2022 Lot # DA327.
rigorous chills, temp of 101.6, headache, body ache and fatigue
Pts wife called on 2/7 reported (L) arm red, swollen and painful. Temperature of 102 on 2-5 and 2-6. Pt had hives as well. On 2/7 all symptoms resolved with exception of tenderness in arm.
Day after shot; numbness in left hand, on top of hand (with slight discoloration - increased redness) this is the same arm injection was given.
Reaction occurred approximately 60 minutes after vaccination.  Flushed and swollen face.  Rapid heart rate.  Some dizziness.   Treated with Benadryl and bed rest.  Symptoms began to subside within 30 minutes after first dose of Benadryl.
9-26-17 6:00pm Redness, swelling, discomfort-worsening by next day 9-27-17. 9-27-17 AM-Fever, chills, malaise, myalgia (very ill) worsening through the night - and continuing- 9-29-17 - called me to Report feeling much better.
Pt recvd vax 13AUG93 & devel pain in lt clavicular area; there was no redness, ecchymosis, swelling nor discoloration of the skin; pt had full ROM; pt exp pain when moved arm greater tha 90 degrees w/abduction;
Per parents, began having reddened area left thigh at site of vaccine from day before - temp last noc + this am. Dad unsure how high, Today 4 cm area induration with erythematous extending 5-6 cm, Center area grayish discoloration 1 cm started on Augmentin.
Pt devel GBS w/quadriplegia p/recvd Typhoid vax; Pt required tx in intensive care unit for 1mo & has been hospitalized for 11 months;
Recurrent afebrile seizures.  Brain MRI/EEG normal.   Doing well on Keppra.
Prior to vax, pt was hyperventilating & crying. Dad had to calm him. Dad reports a post/vax, he was stopped at a red light & looked over at pt & saw his eyes rolled back in head & was rigid so he shook him & he returned to nml.
Covid-19; Covid-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 5 (booster), single (Lot number: GH9694) at the age of 80 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 29Jan2021 as dose 1, single (Lot number: EL9263), on 23Feb2021 as dose 2, single (Batch/Lot number: unknown), on 24Sep2021 as dose 3 (booster), single (Lot number: EC3184) and on 05May2022 as dose 4 (booster), single (Lot number: FM9992) for covid-19 immunisation. The patient's relevant medical history included: "bloodwork was a little bit high" (unspecified if ongoing). Concomitant medication(s) included: PRAVASTATIN taken for blood test abnormal; LEVOTHYROXINE (ongoing). Vaccination history included: Flu shot (She got a flu shot each year; one thing she can say is she got the flu shot for over 65, the stronger one), for Immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 21Aug2023, outcome "recovered" (30Aug2023) and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (21Aug2023) Positive; (30Aug2023) Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt started crying @ 4AM p/receiving shot; Had fever of 101 cried continously for 2 days; MD ordered APAP & no pertussis in future;
Patient was given Menactra intramuscularly at 5:30pm on 11/02/20 .  As soon as I finished giving her the shot, patient claimed she felt sleepy and passed out for a brief 2 seconds.  Patient opened her eyes back after the quick 2 seconds and asked me what happened.  Patient then claimed that she felt drowsy and nauseous.  She also said that her fingers feel numbed and tingling.   Patient was given some water as well as orange juices after which she had more colors on her face and the numbness in her hands went away.   Patient was seated to rest for 30 minutes and felt much better.  She was able to get up and walk on her own and felt completely recovered.  She was accompanied by her brother and her mother who told us that patient has vasovagal syncope.  She had fainted in the past whenever she got blood drawn or got too excited.
Patient experienced soreness and restricted movement in the arm/shoulder. Patient addressed with PCP. Upon assessment, PCP ordered an MRI which indicated injury to the rotator cuff. Patient has referral appt with orthopedic.
No adverse event; HCP calling to report that PROQUAD was administered after undergoing a TE.; This spontaneous report was received from a nurse referring to a unknown age and gender patient. No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided.  On an unknown date in February 2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #W019631, (who had been verified to be a valid number; expiration date: 19-DEC-2023, and upon internal validation established as the same date) administered for prophylaxis (strength and route of administration was not provided). The vaccine was given after it experienced a temperature excursion of 13.5 F (Fahrenheit) with a time frame of 3 hours, 5 minutes, 0 seconds. There was no information about previous temperature excursion (improper storage of product in use). No adverse event was reported.
Mother reports, at 6 month visit, that several hrs after the 4-month shots, baby was screaming inconsolably for 6 hrs and had fever for 3-4 days.  Fully recovered now.
Nausea, vomiting, fever, chills, hives around area vaccine given.
I awoke with burning in my left arm just opposite where I received the shot. It turned a deep red; ulcerated from my armpit to my elbow. I saw 4 doctors and finally diagnosed with microscopic blood clots in my underarm. It was never infected but opened-up. It had a clear liquid center that was about an inch long. It took 4 months to heal with bandages. Applying Aquaphor daily.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 21-AUG-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K005957, expiration date 08-MAR-2015, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 1704 hours with lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Left arm cellulitis - IV antibiotics start on 12/20/02.  Nurse follow up on 06/30/04 states: "ADD: iron deficiency anemia."
pt stated that after he took the vax he woke up cold with fever and chills.  Next morning he woke up feeling better with some light headiness.   Pt says he his symptoms are better now with just a little light headiness.  Pt has not contacted his PCP at this time.
Hive the size of a nickel a week after getting the shot. Taking benadryl and washing with alcohol. Ice.
Patient presented with severe crushing chest pain and was found to have elevated troponin levels. He was diagnosed with myocarditis. Echo showed normal heart function. Cardiac MRI was also done and showed normal heart function with a faint scar suggestive of myocarditis. Overall, findings suggested post vaccine related myocarditis.
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 12-APR-2016, a pharmacist at a pharmacy administered the ZOSTAVAX vaccine to the patient (lot number, dosage and route of administration not provided). In May 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity, and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
But I had COVID. I still got COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (But I had COVID. I still got COVID) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (But I had COVID. I still got COVID). At the time of the report, COVID-19 (But I had COVID. I still got COVID) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient was curious about the patient was given a booster shot, the patients second booster shot, which was through Moderna. But the patient had COVID. The patient still got COVID, so the patient was just curious maybe there was something the patient did not understand about it. This was the second day after the patient found that the patient had COVID.  Treatment information was not provided.
Several weeks after vaccine patient sleeping a lot and losing weight. She had developed a severe case of acne with cyst. Took her to a skin doctor in late December for treatment. Treatment was unsuccessful. Acne devloped and persisted, some acne like cysts, and pox marks that resembled chicken pox. Ran blood work and discoved abnormal levels of varicella zoster virus, and high FT3 which lead to a diagnosis of hyperthyroidism aka Graves disease.
Patient complained of feeling dizzy.  Patient states he is Diabetic.  Spouse  states he didn't eat this morning, just had coffee with his morning meds.  EMS called to car.  Juice, piece of cheese, and a sandwhich was given.  Patient was cleared by EMS.  Before leaving patient denied any symptoms saying he felt much better.  Patient was instructed to seek medical attention if symptoms re appear.  Verbalized understanding.  Spouse present at time and verbalized understanding also.
Hospital called and said pt in on 03/19/2005 to ER for allergic reaction to immunization. States was on left leg-was reddened, 03.25cm medial and 5 cm from injection site. Dr recommended Benadryl and cool compress to the site. TC to mom and said she was right leg and fever, but better now.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 58 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no known allergies and the patient was doing well and had no adverse event. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 202A21A expiry: 21-SEP-2021) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210944479.
swollen arm; This spontaneous case was reported by a physician and describes the occurrence of PERIPHERAL SWELLING (swollen arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) solution for injection for Plaque psoriasis.    No Medical History information was reported.   In 2019, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 1 dosage form. In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jun-2021, the patient experienced PERIPHERAL SWELLING (swollen arm). At the time of the report, PERIPHERAL SWELLING (swollen arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PERIPHERAL SWELLING (swollen arm) to be probably related.    No treatment information was provided by reporter.  No concomitant medications were reported.   Reporter did not allow further contact
Redness, swelling (L) upper arm, burning of upper arm. Allergic to latex.
Presented moderate to severe edema of left arm site of injection with erythema, induration with mild pain without any fever.
Pain in left side of face/left side of my face was very tender to the touch; Headache/terrible headache; fatigued/extremely tired for 3 days; Injection site pain; Felt very nauseaous; Intravenous route of administration; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Pain in left side of face/left side of my face was very tender to the touch), HEADACHE (Headache/terrible headache), FATIGUE (fatigued/extremely tired for 3 days), INJECTION SITE PAIN (Injection site pain) and NAUSEA (Felt very nauseaous) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D22A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Anxiety.    On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2021, the patient experienced FACIAL PAIN (Pain in left side of face/left side of my face was very tender to the touch), HEADACHE (Headache/terrible headache), FATIGUE (fatigued/extremely tired for 3 days), INJECTION SITE PAIN (Injection site pain), NAUSEA (Felt very nauseaous) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Intravenous route of administration). On 25-Jun-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Intravenous route of administration) had resolved. On 27-Jun-2021, INJECTION SITE PAIN (Injection site pain) had resolved. On 02-Jul-2021, FACIAL PAIN (Pain in left side of face/left side of my face was very tender to the touch), HEADACHE (Headache/terrible headache), FATIGUE (fatigued/extremely tired for 3 days) and NAUSEA (Felt very nauseaous) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not reported. The treatment information was not provided. The concurrent condition of the patient was reported as problems with cholesterol.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Follow up document was received and had significant information. Added patient demographics, new events( nausea ).Updated outcome of events from not recovered to recovered, stop date of the events.
has three vaccine at one time and died; heart attack; This is a spontaneous report from a contactable consumer. A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) as single dose, for covid-19 immunisation. Patient received pneumonia vaccine (unspecified) and flu vaccine (unspecified) that day, she had three vaccine at one time. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: intentional product misuse (death), outcome "fatal", described as "has three vaccine at one time and died"; myocardial infarction (death), outcome "fatal", described as "heart attack". Patient passed away after receiving three vaccine; she had three vaccine at one time and died; she was found dead in her apartment. Patient had a heart attack. The patient date of death was unknown. The reported cause of death was myocardial infarction. It was not reported if an autopsy was performed.  The lot number for BNT162B2 was not provided and will be requested during follow up. ; Reported Cause(s) of Death: heart attack
Got shot at 10AM by 8PM had flu-like symptoms - high fever 103 degrees F, achiness, shaking, chills for 2-3 hrs. Fever decreased to 101.5 the next morning. Couple of days afterward still felt extremely tired and achy.
administered Partial MMRII Dose specific to Corresponding 2nd MMRII Dose / '25%' MMRII Intended Dose; no adverse event; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.  The patient's pertinent medical history, concurrent conditions, drug reactions/allergies were not reported. Concomitant medications included varicella virus vaccine live (oka/merck) (VARIVAX) which the patient received on the same day as measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II).   On an unknown date, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (exact dose, strength, lot #, expiry date, route of administration) 25% intended dose, partial dose specific to corresponding second M-M-R II dose (Underdose) for prophylaxis. No additional adverse event (No adverse event) reported.
DTAP-arm turned red from elbow to shoulder;Varicella-rash approximately 1/2 in around needle site; Flu-rash around needle site approximately 1 inch
This is a spontaneous report from a contactable nurse reported for herself. A 60-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot EL3247) intramuscular in right arm on 01Feb2021 at 11:30 am (at 60 years) at single dose for covid-19 immunisation .  Medical history included hypertension (HTN) , hypergammaglobulinaemia benign monoclonal (MGUS) , mononucleosis (recent mononucleosis one year before).  Patient was not pregnant. Concomitant medication included venlafaxine hydrochloride (EFFEXOR), hydrochlorothiazide/ losartan potassium (HYZAAR), amfepramone hydrochloride (TENUATE). The patient previously took IV dramamine, tetanus and ceclor and experienced allergy. Previously, on 18Jan2021 at 10:30 am (at 60 years) she took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot EL3248) intramuscular in right arm for covid-19 immunisation.  Patient took the 1st dose of the vaccine on 18Jan2021 and 2nd dose on 01Feb2021 (inappropriate schedule of vaccine administered). Events were described as follows: next day, on 02Feb2021 at 06:00  temperature of 100.6, arthralgias and myalgias, dizziness.  Second day (Feb2021), temp lower but still around 99.8 (normal for her 97.2), vasovagal, dizziness, arthralgias and myalgias. Events were non serious. Patient (a nurse) treated herself with dramamine for the dizziness,  Nyquil and Advil. The final outcome of pyrexia, vasovagal, dizziness, arthralgias and myalgias  was recovering.
Swelling; pain and rash at injection site; fatigue; headache; weakness; temperature.
04/26/2012 Moderate Other Pt had PNUE23 in left arm. Had swelling to elbow. Went to urgent care and received steroids.
Excessive crying. Patient has been inconsolable since immunizations given. TYLENOL given by mom at 1:00pm. MOTRIN given in doctor's office at 4:13pm.
Sore arm; Major headache; Minor aches and pain; Rash on chest and stomach; Rapid heart beat; This is a spontaneous report from a contactable consumer (Patient). A 58-years-old non pregnant female patient received first dose bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9262), via an unspecified route of administration in Arm Left on 31Jan2021 15:30 as single dose for covid-19 immunisation. Medical history included pre diabetic, Allergies to penicclun/amoxcicilun. Concomitant medications the patient received within 2 weeks of vaccination included multi vitamins,VC, VD, Zinc,krill oil, Magnesiam. The patient previously took amoxicillin and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Feb2021 12:00, The patient experienced sore arm, major headache, minor aches and pain, rash on chest and stomach, rapid heartbeat. AE occurred as follows: sore arm that evening, next day major headache along with minor aches and pain, following day rash on chest and stomach that evening rapid heart-beat for about 20 min. Location of injection information is available for all vaccines received on the same date. No treatment was received for the adverse events occurred. The outcome of the events was recovering.
No adverse event. Baby rec'd Tdap (Adacel) instead of Hep B Vac
redness, swelling, pain arm circumfrential entire upper arm;back pain rt side down to waist;swollen lymph nodes (ax) rt deltoid area;
After receiving shot, the next day...both wrists, left and right...turned: BLACK. 4 months later, left wrist has greatly faded. Right wrist, continues to show slight darkness.   People could not believe this when I showed them. Sorry about long delay in reporting this. My wife has been suggesting I get this information to you...